BIOMERICA, INC. (BMRA) Operating margin 2017–2026
BIOMERICA, INC. (BMRA) operating margin by fiscal year — reported operating income divided by reported revenue.
-119.5%FY2026 · since FY2017: -16.5% → -119.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -119.5% | -22.7 pp |
| FY2025 | -96.7% | +20.9 pp |
| FY2024 | -117.6% | +17.7 pp |
| FY2023 | -135.3% | -111.3 pp |
| FY2022 | -24.0% | +80.2 pp |
| FY2021 | -104.2% | -63.2 pp |
| FY2020 | -41.0% | +5.4 pp |
| FY2019 | -46.4% | -19.8 pp |
| FY2018 | -26.6% | -10.1 pp |
| FY2017 | -16.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BMRA financial trends
BMRA RevenueBMRA Net incomeBMRA Net marginBMRA Gross profitBMRA Gross marginBMRA Operating incomeBMRA Operating cash flowBMRA Free cash flowBMRA Capital expendituresBMRA Return on equityBMRA Stock buybacksBMRA Dividends paidBMRA Total assetsBMRA Total liabilitiesBMRA Shareholders’ equityBMRA overview →